Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer

SIMPLE SUMMARY: As sarcopenia is recognized as a poor prognostic factor in various type of cancers, we hypothesized that sarcopenia may also have adverse impact in patients with metastatic hormone-sensitive prostate cancer (mHSPC). In this study, we found that sarcopenia is an independent prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hyun, Jee, Byul A, Kim, Jae-Hun, Bae, Hoyoung, Chung, Jae Hoon, Song, Wan, Sung, Hyun Hwan, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Park, Se Hoon, Kang, Minyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699789/
https://www.ncbi.nlm.nih.gov/pubmed/34944964
http://dx.doi.org/10.3390/cancers13246345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699789/
https://www.ncbi.nlm.nih.gov/pubmed/34944964
http://dx.doi.org/10.3390/cancers13246345

Ejemplares similares